BR112017017572A2 - material metálico antitrombogênico, e, dispositivo médico implantável. - Google Patents

material metálico antitrombogênico, e, dispositivo médico implantável.

Info

Publication number
BR112017017572A2
BR112017017572A2 BR112017017572-0A BR112017017572A BR112017017572A2 BR 112017017572 A2 BR112017017572 A2 BR 112017017572A2 BR 112017017572 A BR112017017572 A BR 112017017572A BR 112017017572 A2 BR112017017572 A2 BR 112017017572A2
Authority
BR
Brazil
Prior art keywords
metallic material
antithrombotic
derivative
phosphonic acid
catechol
Prior art date
Application number
BR112017017572-0A
Other languages
English (en)
Japanese (ja)
Other versions
BR112017017572B1 (pt
Inventor
Kadowaki Koji
Fujita Masaki
Sakaguchi Yuka
Tanahashi Kazuhiro
Original Assignee
Toray Industries, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries, Inc. filed Critical Toray Industries, Inc.
Publication of BR112017017572A2 publication Critical patent/BR112017017572A2/pt
Publication of BR112017017572B1 publication Critical patent/BR112017017572B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A61L33/0023—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate using a quaternized group or a protonated amine group of the substrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A61L33/0029—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate using an intermediate layer of polymer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A61L33/0035—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate using a polymer with positively charged atoms in the polymeric backbone, e.g. ionenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A61L33/0041—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate characterised by the choice of an antithrombatic agent other than heparin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0076—Chemical modification of the substrate
    • A61L33/0082—Chemical modification of the substrate by reacting with an organic compound other than heparin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/02—Use of inorganic materials
    • A61L33/022—Metal or alloys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/04—Use of organic materials, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/06—Use of macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/06—Use of macromolecular materials
    • A61L33/064—Use of macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/06—Use of macromolecular materials
    • A61L33/068—Use of macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/02—Treatment of implants to prevent calcification or mineralisation in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/18—Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Materials For Medical Uses (AREA)

Abstract

a presente invenção aborda o problema de fornecer um material metálico antitrombótico que melhorou a segurança contra baixa toxicidade hemolítica e pode exibir altas propriedades antitrombóticas de modo sustentável. a presente invenção fornece um material metálico antitrombótico que compreende um material metálico cuja superfície é revestida com um material de revestimento, sendo que o material de revestimento compreende um derivado de ácido fosfônico ou um derivado de catecol; um polímero que contém, como um monômero constituinte, um composto selecionado dentre o grupo que consiste em alquilenoimina, vinilamina, alilamina, lisina, protamina e cloreto de dialildimetilamônio e um composto que contém átomo de enxofre que tem uma atividade anticoagulante aniônica, o polímero é ligado de modo covalente ao derivado de ácido fosfônico ou ao derivado de catecol, o derivado de ácido fosfônico ou o derivado de catecol é ligado ao material metálico através de um grupo ácido fosfônico ou um grupo catecol contido no derivado, e a razão da quantidade de átomos de nitrogênio para a quantidade total de todos os átomos é 4,0 a 13,0% em número atômico quando a superfície do material metálico antitrombótico é medida por uma espectroscopia de fotoelétrons excitados por raios x (xps).
BR112017017572-0A 2015-03-31 2016-03-31 Material metálico antitrombogênico, e, dispositivo médico implantável BR112017017572B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2015071588 2015-03-31
JP2015-071588 2015-03-31
JP2015106974 2015-05-27
JP2015-106974 2015-05-27
PCT/JP2016/060679 WO2016159243A1 (ja) 2015-03-31 2016-03-31 抗血栓性金属材料

Publications (2)

Publication Number Publication Date
BR112017017572A2 true BR112017017572A2 (pt) 2018-05-08
BR112017017572B1 BR112017017572B1 (pt) 2021-10-05

Family

ID=57006040

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017017572-0A BR112017017572B1 (pt) 2015-03-31 2016-03-31 Material metálico antitrombogênico, e, dispositivo médico implantável

Country Status (9)

Country Link
US (1) US10709822B2 (pt)
EP (1) EP3278819B1 (pt)
JP (1) JP6788796B2 (pt)
KR (1) KR20170133321A (pt)
CN (1) CN107405431B (pt)
BR (1) BR112017017572B1 (pt)
CA (1) CA2979779C (pt)
RU (1) RU2711652C2 (pt)
WO (1) WO2016159243A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6859799B2 (ja) * 2017-03-29 2021-04-14 三菱マテリアル株式会社 ペースト状銀粉組成物、接合体の製造方法および銀膜の製造方法
RU2020114003A (ru) 2017-09-29 2021-10-29 Торэй Индастриз, Инк. Антитромботический медицинский материал с применением никель-титанового сплава
US20200360562A1 (en) * 2017-11-30 2020-11-19 The Trustees Of Princeton University Adhesion layer bonded to an activated surface
CN112933302B (zh) * 2021-02-02 2022-06-03 四川大学华西医院 基于中药厚朴的多功能生物医用涂层材料及其制备方法
CN114452449A (zh) * 2022-02-10 2022-05-10 自贡市第一人民医院 可抑制血管内皮细胞炎症的支架涂层及其制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6047287B2 (ja) * 1977-12-15 1985-10-21 ユニチカ株式会社 抗血栓性ポリアミドの製造方法
SE456347B (sv) * 1982-02-09 1988-09-26 Ird Biomaterial Ab Ytmodifierat fast substrat samt forfarande for framstellning derav
US5672638A (en) * 1995-08-22 1997-09-30 Medtronic, Inc. Biocompatability for solid surfaces
US5811151A (en) * 1996-05-31 1998-09-22 Medtronic, Inc. Method of modifying the surface of a medical device
JP3938418B2 (ja) 1996-09-25 2007-06-27 テルモ株式会社 ステント
JP3228409B2 (ja) * 1997-12-05 2001-11-12 東洋紡績株式会社 血液適合性組成物および医療用具
KR100336508B1 (ko) 1999-03-06 2002-05-15 정명호 혈관용 맥 스텐트의 헤타린 코팅방법
JP3874595B2 (ja) * 2000-08-01 2007-01-31 Ｔｃｍ株式会社 横行システムを持ったフォークリフト
US20040213818A1 (en) 2001-06-05 2004-10-28 Susumu Kashiwabara Antithrombotic compositions and medical instruments containing the same
CN1257753C (zh) * 2003-04-28 2006-05-31 浙江大学 采用静电自组装制备抗凝血生物材料的方法
DE10322182A1 (de) * 2003-05-16 2004-12-02 Blue Membranes Gmbh Verfahren zur Herstellung von porösem, kohlenstoffbasiertem Material
EP1982772A1 (de) 2003-05-16 2008-10-22 Cinvention Ag Biokompatibel beschichtete medizinische Implantate
CN1194778C (zh) * 2003-05-27 2005-03-30 中国人民解放军第四军医大学第一附属医院 与血液接触的医疗辅助设备肝素涂层的制备方法
CA2590515A1 (en) 2004-11-26 2006-06-01 Stentomics Inc. Chelating and binding chemicals to a medical implant, medical device formed, and therapeutic applications
EP3225216A1 (en) * 2005-04-05 2017-10-04 Elixir Medical Corporation Degradable implantable medical devices
JP4982752B2 (ja) 2007-02-01 2012-07-25 国立大学法人東北大学 タンパク質および細胞が内壁に固定された中空構造体
US20090018642A1 (en) * 2007-03-15 2009-01-15 Boston Scientific Scimed, Inc. Methods to improve the stability of celluar adhesive proteins and peptides
US8383156B2 (en) * 2007-04-30 2013-02-26 Cordis Corporation Coating for a medical device having an anti-thrombotic conjugate
AU2010339654B2 (en) * 2009-12-21 2014-07-17 Innovative Surface Technologies, Inc. Coating agents and coated articles
EP2428503B1 (de) * 2010-09-10 2014-12-10 Justus-Liebig-Universität Gießen Synthese von tripodalen Catecholderivaten mit einem flexiblen Grundgerüst zur Funktionalisierung von Oberflächen
KR101257996B1 (ko) * 2010-11-01 2013-04-30 아주대학교산학협력단 폴리페놀산화효소를 이용한 생리활성 물질의 표면 고정화 방법
RU2625756C2 (ru) * 2011-03-11 2017-07-18 В.Л. Гор Энд Ассошиейтс, Инк. Усовершенствованные иммобилизованные биологические объекты
JP5576441B2 (ja) 2012-07-19 2014-08-20 チョンナム ナショナル ユニバーシティ ホスピタル ステント表面のヘパリンコーティング方法
RU2655773C2 (ru) * 2013-04-12 2018-05-29 Торэй Индастриз, Инк. Антитромботический искусственный кровеносный сосуд
CN103463675B (zh) * 2013-08-23 2014-10-08 广州军区广州总医院 一种抗菌抗肿瘤骨科植入材料及其制备方法

Also Published As

Publication number Publication date
CA2979779A1 (en) 2016-10-06
KR20170133321A (ko) 2017-12-05
WO2016159243A1 (ja) 2016-10-06
RU2711652C2 (ru) 2020-01-17
RU2017134610A3 (pt) 2019-08-14
CN107405431A (zh) 2017-11-28
JP6788796B2 (ja) 2020-11-25
CA2979779C (en) 2023-06-20
BR112017017572B1 (pt) 2021-10-05
EP3278819A4 (en) 2019-01-02
US10709822B2 (en) 2020-07-14
RU2017134610A (ru) 2019-04-04
EP3278819B1 (en) 2020-07-15
CN107405431B (zh) 2021-02-02
JPWO2016159243A1 (ja) 2018-01-18
EP3278819A1 (en) 2018-02-07
US20180344906A1 (en) 2018-12-06

Similar Documents

Publication Publication Date Title
BR112017017572A2 (pt) material metálico antitrombogênico, e, dispositivo médico implantável.
BR112016005288A2 (pt) Polímero de álcool vinílico, agente espessante, estabilizador para polimerização em emulsão, estabilizador para polimerização em suspensão, agente de revestimento, artigo revestido, agente de colagem para fibras, fios colados e método para produzir tecido
MY186244A (en) Polymer latex composition for dip-molding applications
BR112012023283A2 (pt) cosmético de cabelo
BR112017018488A2 (pt) compósito contendo uma nanoestrutura de carbono, processos para preparação do compósito contendo uma nanoestrutura de carbono e de um material macromolecular, material macromolecular, e, uso do material macromolecular.
BR112017009277A2 (pt) compostos de silicone
BR112014012857A2 (pt) composições resistentes à lavagem contendo aminosilicone
BR112019003568A2 (pt) composição fotocurável
BR112021017012A2 (pt) Composição de imersão aquosa
BR112014004367A2 (pt) mancal, método para fabricar uma composição de revestimento de superfície autolubrificante e composição de revestimento de superfície autolubrificante
BR112015015408A2 (pt) composição de revestimento, e, artigo revestido
BR112018000443A2 (pt) (co)polímero de aditivo de revestimento, e, formulação de revestimento.
AR100173A1 (es) Composiciones de recubrimiento acuosas de dos componentes, y recubrimientos preparados con ellas provistos de una elevada resistencia contra la erosión
BR112013032392A8 (pt) Metal de superfície tratada e método para produzir o mesmo
BR112014018020A8 (pt) Semente revestida; composição farmacêutica revestida; kit para a detecção de um analito; stent revestido; e método
BR112018004740A2 (pt) produto moldado e composições polimerizáveis para materiais óticos
BR112017001186A2 (pt) dispersão de poli(acetato de vinil) e formulação de tinta compreendendo a mesma
BR112018074986A2 (pt) materiais de embalagem contendo celulose oxidada
BR112019004271A2 (pt) composições desodorantes e antiperspirantes
BR112019007744A2 (pt) composição de revestimento aquosa, e, métodos de preparação da composição de revestimento aquosa e de concessão de estabilidade de congelamento e descongelamento a um polímero de emulsão acrílica.
BR112017002696A2 (pt) revestimento de fusão de poliamida por calor
PH12016501343A1 (en) Emulsion composition for skin
BR112017011110A2 (pt) polissiloxanos como sistemas de distribuição de fragrância em perfumaria fina
BR112017013370A2 (pt) composição tensoativa
AR098978A1 (es) Composición de hemicelulosa e hidrogel que la comprende

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 31/03/2016, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 7A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2716 DE 24-01-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.